TABLE 2.
Summary of test results for patients with discordant results between OraQuick and EIAa
| Specimen identification no. | OraQuick | EIA (SCR) | CIA (SCR) | HCV RNA |
|---|---|---|---|---|
| 1 | Positive | Negative (0.007) | Negative (0.02) | Negative |
| 2 | Positive | Negative (0.31) | Positive (1.18) | Negative |
| 3 | Positive | Negative (0.016) | Negative (0.02) | Negative |
| 4 | Positive | Negative (0.013) | Negative (0.02) | Negative |
| 5 | Positive | Negative (0.043) | Negative (0.43) | Negative |
| 6 | Positive | Negative (0.011) | Negative (0.01) | Negative |
| 7 | Negative | Positive (5.123) | Positive (12.9) | Negative |
a
SCR, signal-to-cutoff ratio. Specimens were considered as reactive for antibody to HCV if the SCR was ≥1.0 in both EIA and chemiluminescence immunoassay (CIA). The HCV RNA test was performed using the Cobas Amplicor HCV test, v2.0.